IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Anthera Pharmaceuticals Inc (ANTH)

Q3 2025 vs Q4 2025

Comparing institutional holders between quarters

Quarters

Q4 2025Q3 2025Q4 2019Q3 2018Q2 2018
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Steigerwald, Gordon & Koch Inc.
UNCHANGED
Shares25 from 25
Change0 (0%)
Value$0 ($0)
Filed 2026-01-23
Status
Steigerwald, Gordon & Koch Inc.
UNCHANGED252500%$0$0$02026-01-23
Showing 1 of 1 institutions